Rate of diagnoses and cost following thyroid imaging after benign fine-needle aspiration.
Follow-up imaging of the thyroid after benign fine-needle aspiration (FNA) is costly and results only in a small rate of subsequent malignancy detection, according to a study published in the American Journal of Roentgenology.
Researchers from Pennsylvania, Maryland, and Michigan sought to determine patterns, the cost of imaging tumor surveillance, and the rate of subsequent cancer detection in patients after an FNA biopsy of the thyroid.
The study included patients who had a benign thyroid FNA biopsy between January 1, 1999, and December 31, 2003, as identified from an institutional pathology database. Information was gathered from electronic medical records on imaging tumor surveillance and subsequent cancer detection. Cost was determined using the facility total relative value unit and the 2014 Hospital Outpatient Prospective Payment System conversion factor.
The results showed that 1,685 patients were determined to have a benign thyroid FNA biopsy, 800 (47.5%) of whom underwent follow-up imaging. The total cost for the procedures was $879,347 or $1099 per patient:
The mean length of follow-up was 7.3 years, during which time 19 (2.4%) patients were diagnosed with thyroid cancer at a cost of $46,281 per cancer. Seventeen (89.5%) were diagnosed with papillary carcinoma and two (10.5%) with Hurthle cell carcinoma.
The researchers concluded that although half of patients with a benign thyroid FNA biopsy underwent follow-up imaging, it was at considerable cost with a small rate of subsequent malignancy.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.